Editorial: Interleukin-7 and Its Receptor: The Axis of Evil to Target in Sjogren's Syndrome?

被引：7
|
作者：
van Roon, Joel A. G. [1 ]
Kruize, Aike A. [1 ]
Radstake, Timothy R. D. J. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷 / 08期
关键词：
SALIVARY-GLANDS; T-CELLS; EXPRESSION; TH1;
D O I：
10.1002/art.38002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1980 / 1984
页数：5
相关论文
共 50 条
  • [31] The interleukin-7 receptor α chain contributes to altered homeostasis of regulatory T cells in multiple sclerosis
    Haas, Juergen
    Korporal, Mirjam
    Schwarz, Alexander
    Balint, Bettina
    Wildemann, Brigitte
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (03) : 845 - 853
  • [32] Serum interleukin-17 & nitric oxide levels in patients with primary Sjogren's syndrome
    Miletic, M.
    Stojanovic, R.
    Pajic, O.
    Bugarski, D.
    Mojsilovic, S.
    Cokic, V.
    Milenkovic, P.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 135 (04) : 513 - 519
  • [33] Concentration and Activity of the Soluble Form of the Interleukin-7 Receptor α in Type 1 Diabetes Identifies an Interplay Between Hyperglycemia and Immune Function
    Monti, Paolo
    Brigatti, Cristina
    Krasmann, Miriam
    Ziegler, Anette G.
    Bonifacio, Ezio
    DIABETES, 2013, 62 (07) : 2500 - 2508
  • [34] Autoantibodies in Sjogren's syndrome and its classification criteria
    Veenbergen, Sharon
    Kozmar, Ana
    van Daele, Paul L. A.
    Schreurs, Marco W. J.
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2022, 5
  • [35] Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis
    Chen, Deng
    Tang, Ting-Xuan
    Deng, Hai
    Yang, Xiang-Ping
    Tang, Zhao-Hui
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model
    Byun, Hwa Kyung
    Kim, Kyoung-Jin
    Han, Su Chul
    Seong, Jinsil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1559 - 1569
  • [37] Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjogren's syndrome
    Nayar, Saba
    Campos, Joana
    Smith, Charlotte G.
    Iannizzotto, Valentina
    Gardner, David H.
    Colafrancesco, Serena
    Pipi, Elena
    Kollert, Florian
    Hunter, Kelly J.
    Brewer, Charlotte
    Buckley, Christopher Dominic
    Bowman, Simon J.
    Priori, Roberta
    Valesini, Guido
    Juarez, Maria
    Fahy, William A.
    Fisher, Benjamin A.
    Payne, Andrew
    Allen, Rodger A.
    Barone, Francesca
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (02) : 249 - 260
  • [38] B cells in Sjogren's syndrome: from pathophysiology to therapeutic target
    Mielle, Julie
    Tison, Alice
    Cornec, Divi
    Le Pottier, Laetitia
    Daien, Claire
    Pers, Jacques-Olivier
    RHEUMATOLOGY, 2021, 60 (06) : 2545 - 2560
  • [39] IL-17, a potential therapeutic target for Sjogren's syndrome?
    Liu, Shan-Shan
    Ding, Ye
    Lou, Ji-Quan
    CLINICAL RHEUMATOLOGY, 2015, 34 (09) : 1657 - 1658
  • [40] Current and Emerging Evidence for Toll-Like Receptor Activation in Sjogren's Syndrome
    Kiripolsky, Jeremy
    Kramer, Jill M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
12345